If You Invested in LIGAND PHARMS GLUCAGON (LGNXZ)
Looking for the current price? See the LGNXZ quote & overviewWhat $1,000 or $10,000 in LGNXZ Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Dec 31, 2021 |
|---|---|---|---|---|
| $1,000 | $2,308 +131% | — | — | $500 -50% |
| $10,000 | $23,077 +131% | — | — | $5,000 -50% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-10-20. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for LGNXZ$1,000 Investment Over Time
LGNXZ vs S&P 500Year-by-Year Returns
LGNXZ annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2022 | $0.0060 | $0.0050 | -16.7% | -16.7% |
| 2023 | $0.0050 | $0.0013 | -74.0% | -78.3% |
| 2024 | $0.0013 | $0.0032 | +146.2% | -46.7% |
| 2025 | $0.0032 | $0.0012 | -62.5% | -80.0% |
| 2026 | $0.0012 | $0.0030 | +150.0% | -50.0% |
About LIGAND PHARMS GLUCAGON
OTC
Frequently Asked Questions
LIGAND PHARMS GLUCAGON investment returns
How much would $1,000 invested in LIGAND PHARMS GLUCAGON be worth today?
If you invested $1,000 in LIGAND PHARMS GLUCAGON (LGNXZ) 1 years ago on 2025-10-27, your investment would be worth $2,308 as of 2026-10-20, a +130.8% price return without dividends, growing at a compounded rate of 134.7% per year (CAGR).
Has LIGAND PHARMS GLUCAGON outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare LGNXZ performance over available time periods.
What is LIGAND PHARMS GLUCAGON's average annual return?
The compound annual growth rate (CAGR) of LGNXZ’s share price over the past 1 years is 134.7%, without dividends. Individual years vary a great deal, and LGNXZ’s best recent full year was 2024 (+146.2%) while the worst was 2024 (+146.2%).
For informational and educational purposes only, not investment advice.
